-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Upgrades Iovance Biotherapeutics to Market Outperform, Announces $5 Price Target

Benzinga·02/25/2026 12:15:03
Listen to the news
Citizens analyst Reni J. Benjamin upgrades Iovance Biotherapeutics (NASDAQ:IOVA) from Market Perform to Market Outperform and announces $5 price target.